In May, the Department of Health and Human Services published a comprehensive review of treatments for gender dysphoria in minors that was swiftly criticized, in part because the names of its authors were withheld.
I am one of the authors. As Health and Human Services said upon publication, the review is going through the peer review process, for which anonymity is preferred.
…
The hostile response to the review by medical groups and practitioners underscores why it was necessary. Medicalized treatment for pediatric gender dysphoria needs to be dispassionately scrutinized like any other area of medicine, no matter which side of the aisle is cheering it on. But in the United States, it has not been.
Related on the SLP
Though the current administration seems not to grasp the point, we all stand to benefit from free and open inquiry, in medicine, academia and in society more broadly. That does not mean elevating crackpots or taking wild conspiracy theories seriously. It means that objections should be made using arguments and data, not shaming or ostracizing.


















